CT-derived simulations to predict outcomes in patients undergoing transcatheter aortic valve implantation with an ACURATE Neo2 valve the PRECISE-TAVI cohort B trial.
Thijmen W HokkenPhilippe NuyensClaudio RuffoRutger-Jan NuisJoost DaemenIsabella KardysRicardo BuddeNicola BuzzattiOle de BackerNicolas M D A van MieghemPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
In our study FEops HEARTguide™ simulations identified patients at risk for >trace PVL with ACURATE Neo2 TAVI but not for PPI.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve replacement
- patients undergoing
- end stage renal disease
- molecular dynamics
- chronic kidney disease
- clinical trial
- peritoneal dialysis
- image quality
- mitral valve
- prognostic factors
- coronary artery disease
- heavy metals
- heart failure
- atrial fibrillation
- magnetic resonance
- monte carlo
- phase ii
- patient reported outcomes
- metabolic syndrome
- risk assessment
- magnetic resonance imaging
- dual energy
- phase iii